School of Medicine
Showing 1-4 of 4 Results
-
Dan Riskin
Clinical Professor (Affiliated), Surgery - General Surgery
Staff, Surgery - General SurgeryBioDr. Riskin is Clinical Professor of Surgery. His research interests include healthcare quality, technology, and policy. With a focus on translational research, developed products are in use by leading health systems and insurers influencing the care of millions of patients.
Dr. Riskin's medical credentials include a MD from Boston University, residency in surgery at UCLA, and fellowship in critical care and acute care surgery at Stanford University. He is board-certified in four specialties, including surgery, critical care, palliative care, and clinical informatics. His business training includes a MBA with a focus in bioinformatics from the Massachusetts Institute of Technology and the Stanford Biodesign Innovation Fellowship. -
Brian Ruhle, MD, MS
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Ruhle is a board-certified surgeon with dual fellowship training in bariatric and minimally invasive surgery from Stanford Health Care and endocrine surgery from UCLA Health. He also serves as a clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Ruhle specializes in bariatric (weight loss) surgery, foregut (upper digestive tract) surgery, and abdominal wall reconstruction. He uses leading-edge laparoscopic and robotic surgical techniques to help patients achieve sustainable weight loss and improve obesity related health conditions. His expertise in advanced minimally invasive procedures offers patients significant benefits, including faster recoveries, reduced pain, and shorter hospital stays.
Dr. Ruhle’s research interests span a wide range of topics in metabolic and bariatric surgery. His studies have explored combination therapy for obesity management, improved screening and treatment of endocrine disorders, and optimizing outcomes in thyroid and parathyroid surgery. He has published his findings in numerous peer-reviewed journals, including Surgery, Journal of Gastrointestinal Surgery, Blood, and Journal of the American College of Surgeons.
During his surgical training, Dr. Ruhle presented at prominent national and regional meetings, including the annual meetings of the American Association of Endocrine Surgeons and American College of Surgeons Clinical Congress. His presentations have addressed innovative topics such as using GLP-1 agonists (medications that help regulate blood sugar and reduce appetite) before bariatric surgery. His presentations have also addressed improving screening protocols for hyperaldosteronism (high blood pressure caused by the excess production of the hormone aldosterone).
Dr. Ruhle is a member of the American Association of Endocrine Surgeons, American Society for Metabolic and Bariatric Surgery, Clinical Association of California Endocrinologists, and Society of American Gastrointestinal and Endoscopic Surgeons.
